SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Babe Didrikson Zaharias — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Mildred Ella Didrikson Zaharias |
|---|
| Date of birth | 1911-06-26 |
|---|
| Identifiers | MRN HR-ML038-SYN-TD; SSN (made up) 000-38-4471 |
|---|
| Document date | 1953-06-01 |
|---|
| Author | Rosalind Vasquez-Thornbury, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Cough, sore throat and a low fever for three days, on immunotherapy. [S]
History of Present Illness
Ms. Didrikson Zaharias called the oncology line three days into a cough and was seen the same day. She had three doses of dostarlimab, the last two weeks ago, and cycle 4 is due in a week. The illness began with a scratchy throat and a runny nose after a tournament week in which several players in the locker room had colds. She now has a dry cough, worse at night, and a temperature up to 37.9 °C at home. She is not short of breath, even climbing the slope to the eighteenth green, and has no chest pain. She has no diarrhea, rash, or abdominal pain, and her bowel movements have been normal since the second dose, with no blood. She has felt more tired than usual for about two weeks, before the cold began. She is practicing but skipped yesterday's round. She has had no thoughts of self-harm. [S]
| Element | Detail |
|---|
| Onset | Three days ago, after colds among players at a tournament |
| Severity | Dry cough, worse at night; temperature up to 37.9 °C; not short of breath |
| Context | Three doses of dostarlimab; a new cough on PD-1 blockade must prompt a check for pneumonitis |
| Associated signs and symptoms | Runny nose and sore throat; tired for two weeks; no diarrhea, rash or chest pain |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Positive | Low fever; tired for about two weeks, before the cold began |
| Ears, nose, mouth, and throat | Positive | Sore throat and runny nose |
| Respiratory | Positive | Dry cough; no breathlessness on exertion, wheeze or blood in the sputum |
| Cardiovascular | Negative | No chest pain, palpitations or leg swelling |
| Gastrointestinal | Negative | Bowel movements normal; no blood, diarrhea or abdominal pain |
| Integumentary | Negative | No rash or itching |
| Endocrine | Negative | No cold intolerance, weight change or thirst |
| Psychiatric | Negative | Annoyed at missing a round; no thoughts of self-harm |
8 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other morning | One tablet every other morning | Oral route | 1953-03-30 | active | S |
| Dostarlimab-gxly 50 mg/mL injection, 500 mg intravenously over 30 minutes every 3 weeks, for nine doses (six months) | 500 mg every 3 weeks for nine doses | Intravenous route | 1953-04-06 to 1953-09-21 | completed | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1953-06-01 | Body height | 168 | cm | S |
| 1953-06-01 | Body weight | 63 | kg | S |
| 1953-06-01 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 1953-06-01 | Systolic blood pressure | 114 | mm[Hg] | S |
| 1953-06-01 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1953-06-01 | Heart rate | 88 | /min | S |
| 1953-06-01 | Respiratory rate | 16 | /min | S |
| 1953-06-01 | Body temperature | 37.9 | Cel | S |
| 1953-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1953-06-01 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 12-15.5 g/dL | Normal | S |
| 1953-06-01 | Leukocytes [#/volume] in Blood by Automated count | 9.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1953-06-01 | Platelets [#/volume] in Blood by Automated count | 290 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1953-06-01 | Thyrotropin [Units/volume] in Serum or Plasma | 5.8 | m[IU]/L | 0.45-4.5 mIU/L | High | S |
| 1953-06-01 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma | 1 | ng/dL | 0.8-1.8 ng/dL | Normal | S |
Physical Exam
Vital signs recorded on 1953-06-01; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Well, talking in full sentences; temperature 37.9 °C; weight 63.0 kg |
| Vital signs | Oxygen saturation 98% at rest and 97% after a brisk walk along the corridor; respiratory rate 16 |
| Head, eyes, ears, nose, and throat | Pharynx red without exudate; nasal congestion; no sinus tenderness; ear drums normal |
| Neck | Small tender anterior cervical nodes; thyroid not enlarged or tender |
| Respiratory | Clear to auscultation bilaterally; no crackles or wheeze |
| Skin | No rash |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Bright red blood with bowel movements for about three months, with narrower stools, urgency, a feeling of incomplete emptying, and a firm, ulcerated mass felt on the back wall of the lower rectum at about 5 cm from the anal verge: a rectal cancer must be confirmed or excluded. Colonoscopy with biopsy booked this week | resolved | confirmed |
K62.5 | S — Synthetic presenting problem anchored to the documented fatigue before her cancer diagnosis. Superseded by the diagnosis at the second visit. |
| Iron deficiency anemia from chronic rectal blood loss: hemoglobin 11.0 g/dL, MCV 77 fL, ferritin 9 ng/mL, with tiredness | active | confirmed |
D50.0 | S — Synthetic finding anchored to the documented fatigue at the end of the 1952 season. |
| Adenocarcinoma of the low rectum, mismatch repair deficient (loss of MSH2 and MSH6; microsatellite instability high), cT3bN1M0 (stage IIIB) on pelvic MRI, lower edge 4 cm from the anal verge and about 1 cm above the anorectal junction, mesorectal fascia clear, no extramural venous invasion; CEA 5.8 ng/mL; synthetic modern detail linked to her documented cancer, whose site the sources do not record exactly | active | confirmed |
C20 | S — Synthetic histology, site, stage, mismatch repair status and course; the sources say she had cancer treated with a colostomy and call it colon cancer (R on the site). See sources.md. |
| Acute viral upper respiratory infection with cough and sore throat, a week before cycle 4 of dostarlimab; oxygen saturation and chest X-ray normal, so immune-related pneumonitis is unlikely; rapid influenza and COVID-19 tests negative; resolved | active | confirmed |
J06.9 | S — Synthetic intercurrent illness; not a historical claim. |
Assessment and Plan
- Acute viral upper respiratory infection (J06.9). A viral cold with cough after exposure on tour. On PD-1 blockade a new cough must raise the question of pneumonitis, but her oxygen saturation is normal at rest and on exertion, the lungs are clear and the chest X-ray is clear, so pneumonitis is unlikely (grade 0). Rapid influenza and COVID-19 tests were negative. No antibiotic is needed. [S]
- Fluids, rest, honey and warm drinks for the cough; acetaminophen for fever.
- Call at once for breathlessness, oxygen saturation below 94% on her home oximeter, chest pain or fever above 38.5 °C; any of these would need a CT of the chest.
- Cycle 4 next week if the fever has gone.
- Mismatch repair-deficient low rectal cancer on dostarlimab (C20). Three doses given; bleeding has stopped and bowel habit is normal. The two weeks of tiredness before the cold led to a thyroid check today: TSH 5.8 mIU/L with a normal free T4 of 1.0 ng/dL, a mild rise from 2.2 at the last visit, which can be the start of immune-related thyroiditis. No treatment is needed at this level. [S]
- TSH and free T4 again before cycle 5, with the restaging visit.
- Restaging MRI and sigmoidoscopy as booked.
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer (current version); summarized in Benson AB, et al. NCCN Guidelines Insights: Rectal Cancer, Version 3.2024. J Natl Compr Canc Netw 2024;22(6):366-375 (PMID 39151454) (2026); Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021;39(36):4073-4126 (PMID 34724392) (2021)
Follow-up: Cycle 4 in one week if afebrile. Restaging and review at cycle 5. Call for breathlessness, chest pain, diarrhea, rash or high fever. Next scheduled visit 1953-06-29: restaging after four doses: pelvic MRI and endoscopy, immune-related hypothyroidism, and the decision to continue PD-1 blockade. [S]